The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma

被引:11
|
作者
Zhang, Jie [1 ]
Shi, Keqing [2 ]
Huang, Weiguo [1 ]
Weng, Wanqing [1 ]
Zhang, Zhongjing [1 ]
Guo, Yangyang [1 ]
Deng, Tuo [1 ]
Xiang, Yukai [1 ]
Ni, Xiaofeng [1 ]
Chen, Bicheng [1 ]
Zhou, Mengtao [1 ,2 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou 325015, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Precis Med Ctr, Affiliated Hosp 1, Wenzhou 325015, Zhejiang, Peoples R China
关键词
DNA methylation; Pancreatic adenocarcinoma; miRNA; lncRNA; Classifier; Prognosis; GASTRIC-CANCER; PROMOTES; EXPRESSION; CELLS; MAPK;
D O I
10.1186/s12935-019-0828-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCompelling lines of evidence indicate that DNA methylation of non-coding RNAs (ncRNAs) plays critical roles in various tumour progression. In addition, the differential methylation of ncRNAs can predict prognosis of patients. However, little is known about the clear relationship between DNA methylation profile of ncRNAs and the prognosis of pancreatic adenocarcinoma (PAC) patients.MethodsThe data of DNA methylation, RNA-seq, miRNA-seq and clinical features of PAC patients were collected from TCGA database. The DNA methylation profile was obtained using the Infinium HumanMethylation450 BeadChip array. LASSO regression was performed to construct two methylation-based classifiers. The risk score of methylation-based classifiers was calculated for each patient, and the accuracy of the classifiers in predicting overall survival (OS) was examined by ROC curve analysis. In addition, Cox regression models were utilized to assess whether clinical variables and the classifiers were independent prognostic factors for OS. The targets of miRNA and the genes co-expressed with lncRNA were identified with DIANA microT-CDS and the Multi-Experiment Matrix (MEM), respectively. Moreover, DAVID Bioinformatics Resources were applied to analyse the functional enrichment of these targets and co-expressed genes.ResultsA total of 4004 CpG sites of miRNA and 11,259 CpG sites of lncRNA were screened. Among these CpG sites, 8 CpG sites of miRNA and 7 CpG sites of lncRNA were found with regression coefficients. By multiplying the sum of methylation degrees of the selected CpGs with these coefficients, two methylation-based classifiers were constructed. The classifiers have shown good performance in predicting the survival rate of PAC patients at varying follow-up times. Interestingly, both of these two classifiers were predominant and independent factors for OS. Furthermore, functional enrichment analysis demonstrated that aberrantly methylated miRNAs and lncRNAs are related to calcium ion transmembrane transport and MAPK, Ras and calcium signalling pathways.ConclusionIn the present study, we identified two methylation-based classifiers of ncRNA associated with OS in PAC patients through a comprehensive analysis of miRNA and lncRNA profiles. We are the first group to demonstrate a relationship between the aberrant DNA methylation of ncRNAs and the prognosis of PAC, and this relationship would contribute to individualized PAC therapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Large-scale integration of the non-coding RNAs with DNA methylation in human cancers
    Shen, Sipeng
    Chen, Jiajin
    Li, Hongru
    Wei, Yongyue
    Jiang, Yunke
    Zhang, Ruyang
    Zhao, Yang
    Chen, Feng
    CELL REPORTS, 2023, 42 (03):
  • [22] DNA methylation patterns of protein-coding genes and long non-coding RNAs in males with schizophrenia
    Liao, Qi
    Wang, Yunliang
    Cheng, Jia
    Dai, Dongjun
    Zhou, Xingyu
    Zhang, Yuzheng
    Li, Jinfeng
    Yin, Honglei
    Gao, Shugui
    Duan, Shiwei
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 6568 - 6576
  • [23] Non-coding RNAs in DNA damage and repair
    Sharma, Vivek
    Misteli, Tom
    FEBS LETTERS, 2013, 587 (13) : 1832 - 1839
  • [24] DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain
    Irfan, Jahanzaib
    Febrianto, Muhammad Rizki
    Sharma, Anju
    Rose, Thomas
    Mahmudzade, Yasamin
    Di Giovanni, Simone
    Nagy, Istvan
    Torres-Perez, Jose Vicente
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [25] Epigenetic modifications as therapeutic targets in atherosclerosis: a focus on DNA methylation and non-coding RNAs
    Sum, Hashum
    Brewer, Alison C. C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [26] Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers
    Wang, Yingxue
    Li, Zhihua
    Zheng, Shangyou
    Zhou, Yu
    Zhao, Lei
    Ye, Huilin
    Zhao, Xiaohui
    Gao, Wenchao
    Fu, Zhiqiang
    Zhou, Quanbo
    Liu, Yimin
    Chen, Rufu
    ONCOTARGET, 2015, 6 (34) : 35684 - 35698
  • [27] Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation
    Yang, Zhen
    Xu, Feng
    Teschendorff, Andrew E.
    Zhao, Yi
    Yao, Lei
    Li, Jian
    He, Yungang
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [28] Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes
    Ma, Xiaoke
    Yu, Liang
    Wang, Peizhuo
    Yang, Xiaofei
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2017, 69 : 164 - 170
  • [29] Bladder cancer: non-coding RNAs and exosomal non-coding RNAs
    Zhao, Jingang
    Ma, Yangyang
    Zheng, Xiaodong
    Sun, Zhen
    Lin, Hongxiang
    Du, Chuanjun
    Cao, Jing
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (05)
  • [30] Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma
    Rahimian, Neda
    Sheida, Amirhossein
    Rajabi, Mohammadreza
    Heidari, Mohammad Mahdi
    Tobeiha, Mohammad
    Esfahani, Pegah Veradi
    Asouri, Sahar Ahmadi
    Hamblin, Michael R.
    Mohamadzadeh, Omid
    Motamedzadeh, Alireza
    Mahabady, Mahmood Khaksary
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248